Skip to main content
. 2021 May 19;11:686621. doi: 10.3389/fonc.2021.686621

Table 4.

Treatment Related Adverse Events.

Adverse Events Any Grade, n (%) Grade 3/4, n (%)
Rash 4(25.0%) 1(6.3%)
Diarrhea 4(25.0%) 0
Aspartate aminotransferase increase 3(18.8%) 1(6.3%)
Alanine transaminase increase 3(18.8%) 1(6.3%)
Decreased appetite 3(18.8%) 0
Fatigue 3(18.8%) 0
Pruritus 2(12.5%) 0
Dental ulcer 2(12.5%) 0
Nausea 2(12.5%) 0
Hypertension 1(6.3%) 0
Infusion-related reaction 1(6.3%) 0
Gastrointestinal hemorrhage 1(6.3%) 1(6.3%)
Blood bilirubin increase 1(6.3%) 0
Weight decrease 1(6.3%) 0